Literature DB >> 32124018

Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP.

David-Dan Nguyen1, Vincent Misraï2, Thorsten Bach3, Naeem Bhojani4, James E Lingeman5, Dean S Elterman6, Kevin C Zorn7.   

Abstract

INTRODUCTION: The BPH surgical armamentarium is composed of a rapidly expanding number of technologies and techniques. These include greenlight photovaporization of the prostate (PVP), greenlight enucleation of the prostate (GreenLEP), holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the prostate (ThuLEP) and, more recently, the aquablation procedure. To the best of our knowledge, no direct comparison in operative time has been performed.
METHODS: Data for this study were pooled from five sources. For aquablation, patient-level data from four studies of the aquablation procedure were provided by the device manufacturer as well as from a high-volume commercial user. PVP, GreenLEP, HoLEP, and ThuLEP were performed by high-volume, experienced experts. Endpoints included total operative time, resection time, and proportion of total operative time for resection. General linear models were used to evaluate the relationship between prostate volume (or other continuous predictors) and procedure time.
RESULTS: Total procedure time was related to prostate size. Except for the small prostate size range (size < 40 cc), at any given prostate volume, procedure time was highest for PVP, intermediate for LEPs, and lowest for Aquablation. The relationship between procedure time and prostate size (i.e., slope of the fitted lines) was 0.16 min/g for aquablation, 0.32 min/g, 0.28 min/g and 0.32 min/g for GreenLEP, HoLEP and ThuLEP, respectively, and 0.63 min/g for PVP.
CONCLUSION: In our analysis of pooled data of multi-surgical techniques and technologies, aquablation provided the lowest operative time across all prostate volumes. PVP had the longest procedure time for prostates > 40 cc.

Entities:  

Keywords:  Aquablation; GreenLEP; Greenlight PVP; HoLEP; Operative time; ThuLEP

Mesh:

Substances:

Year:  2020        PMID: 32124018     DOI: 10.1007/s00345-020-03137-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  21 in total

Review 1.  Current role of lasers in the treatment of benign prostatic hyperplasia (BPH).

Authors:  Rainer M Kuntz
Journal:  Eur Urol       Date:  2006-03-31       Impact factor: 20.096

Review 2.  Holmium laser resection of the prostate.

Authors:  A Le Duc; P J Gilling
Journal:  Eur Urol       Date:  1999-02       Impact factor: 20.096

3.  Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.

Authors:  J Curtis Nickel; Lorne Aaron; Jack Barkin; Dean Elterman; Mahmoud Nachabé; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2018-10       Impact factor: 1.862

4.  Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up.

Authors:  Thorsten Bach; Christopher Netsch; Axel Haecker; Maurice-Stephan Michel; Thomas R W Herrmann; Andreas J Gross
Journal:  World J Urol       Date:  2009-08-09       Impact factor: 4.226

5.  A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.

Authors:  Liam C Wilson; Peter J Gilling; Andrew Williams; Katie M Kennett; Chris M Frampton; Andre M Westenberg; Mark R Fraundorfer
Journal:  Eur Urol       Date:  2006-05-02       Impact factor: 20.096

Review 6.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.

Authors:  Sascha A Ahyai; Peter Gilling; Steven A Kaplan; Rainer M Kuntz; Stephan Madersbacher; Francesco Montorsi; Mark J Speakman; Christian G Stief
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

Review 7.  EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.

Authors:  Christian Gratzke; Alexander Bachmann; Aurelien Descazeaud; Marcus J Drake; Stephan Madersbacher; Charalampos Mamoulakis; Matthias Oelke; Kari A O Tikkinen; Stavros Gravas
Journal:  Eur Urol       Date:  2015-01-19       Impact factor: 20.096

8.  Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia.

Authors:  Amy E Krambeck; Shelly E Handa; James E Lingeman
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450

9.  Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction.

Authors:  Thomas R W Herrmann; T Bach; F Imkamp; A Georgiou; M Burchardt; M Oelke; A J Gross
Journal:  World J Urol       Date:  2010-02       Impact factor: 4.226

Review 10.  Benign prostatic hyperplasia: epidemiology, economics and evaluation.

Authors:  Camille Vuichoud; Kevin R Loughlin
Journal:  Can J Urol       Date:  2015-10       Impact factor: 1.344

View more
  7 in total

1.  Rectal perforation after aquablation of the prostate: lessons learned the hard way.

Authors:  A J Gross; M J Lipp; R Baumbach; B Becker; K Vogt; C Rosenbaum; C Netsch
Journal:  World J Urol       Date:  2021-03-26       Impact factor: 4.226

2.  Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.

Authors:  Kevin C Zorn; Mohamed Bidair; Andrew Trainer; Andrew Arther; Eugene Kramolowsky; Mihir Desai; Leo Doumanian; Dean Elterman; Ronald P Kaufman; James Lingeman; Amy Krambeck; Gregg Eure; Gopal Badlani; Mark Plante; Edward Uchio; Greg Gin; S Larry Goldenberg; Ryan Paterson; Alan So; Mitchell Humphreys; Claus Roehrborn; Steven Kaplan; Jay Motola; Naeem Bhojani
Journal:  BJUI Compass       Date:  2021-10-28

3.  Aquablation for benign prostatic obstruction: Single center technique evolution and experience.

Authors:  Muhieddine Labban; Mazen Mansour; Nicolas Abdallah; Rola Jaafar; Wassim Wazzan; Muhammad Bulbul; Albert El-Hajj
Journal:  Investig Clin Urol       Date:  2021-03

4.  Holmium laser enucleation of the prostate with Virtual Basket mode: faster and better control on bleeding.

Authors:  Giorgio Bozzini; Matteo Maltagliati; Umberto Besana; Lorenzo Berti; Albert Calori; Maria Chiara Sighinolfi; Salvatore Micali; Jean Baptiste Roche; Ali Gozen; Alexander Mueller; Dimitry Pushkar; Evangelos Liatsikos; Marco Boldini; Carlo Buizza; Bernardo Rocco
Journal:  BMC Urol       Date:  2021-02-23       Impact factor: 2.264

5.  Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies.

Authors:  Dean Elterman; Peter Gilling; Claus Roehrborn; Neil Barber; Vincent Misrai; Kevin C Zorn; Naeem Bhojani; Alexis Te; Mitch Humphreys; Steven Kaplan; Mihir Desai; Thorsten Bach
Journal:  BMJ Surg Interv Health Technol       Date:  2021-06-23

6.  Experimental ex-vivo performance study comparing a novel, pulsed thulium solid-state laser, chopped thulium fibre laser, low and high-power holmium:YAG laser for endoscopic enucleation of the prostate.

Authors:  Mehmet Yilmaz; Julia Esser; Lea Kraft; Ralf Petzold; August Sigle; Christian Gratzke; Rodrigo Suarez-Ibarrola; Arkadiusz Miernik
Journal:  World J Urol       Date:  2021-09-03       Impact factor: 4.226

7.  WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm3 and 80-150-cm3 Prostates.

Authors:  David-Dan Nguyen; Neil Barber; Mo Bidair; Peter Gilling; Paul Anderson; Kevin C Zorn; Gopal Badlani; Mitch Humphreys; Steven Kaplan; Ronald Kaufman; Alan So; Ryan Paterson; Larry Goldenberg; Dean Elterman; Mihir Desai; Jim Lingeman; Claus Roehrborn; Naeem Bhojani
Journal:  Eur Urol Open Sci       Date:  2021-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.